Newsfeeds - Spark Newswire

5 minute read

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday’s Mid-Day Session

Today, 11:17 PM

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

ACLX

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

Today, 11:17 PM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG

3 minute read

The Daily Biotech Pulse: FDA Tentatively Approves Avadel’s Narcolepsy Drug, European Approval Broadens AstraZeneca’s Enhertu in Breast Cancer, Pharma Giants’ Earnings

By Vandana Singh

Today, 11:17 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ACAD

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 11:17 PM

Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.

BPTS

2 minute read

FDA
News

Celcuity Announced FDA Breakthrough Therapy Designation for Gedatolisib for Treatment of HR+/HER2- Metastatic Breast Cancer

By Charles Gross

Today, 11:17 PM

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company focused on development of targeted therapies for hormonally driven cancers, today announced that the U.S.

CELC

8 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 11:17 PM

On Tuesday, 123 stocks made new 52-week lows.

ACLX

1 minute read

Earnings

Recap: Celcuity Q1 Earnings

By Benzinga Insights

Today, 11:17 PM

Celcuity (NASDAQ:CELC) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Celcuity beat estimated earnings by 7.84%, reporting an EPS of $-0.47 versus an estimate of $-0.51.

CELC

3 minute read

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More

By Shanthi Rexaline

Today, 11:17 PM

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from mid-cap companies.

ATNX

10 minute read

Earnings Scheduled For May 16, 2022

By Benzinga Insights

Today, 11:17 PM

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

ACRX

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 11:17 PM

On Friday =, 431 companies hit new 52-week lows.

AAOI